• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在生长抑制条件下,对细胞c-myc蛋白含量、S期百分比和生长平衡中发生的调节进行定量分析。

A quantitative analysis of modulations occurring in cellular c-myc protein content, %S phase and growth balance under growth-inhibitory conditions.

作者信息

Engelhard H H

机构信息

Department of Surgery, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

Cell Mol Biol (Noisy-le-grand). 1993 Sep;39(6):607-20.

PMID:8220071
Abstract

The c-myc protein was one of the first proto-oncogene products to be linked to the increased proliferative activity of neoplastic cells. However, few studies have attempted to quantify changes occurring in cellular c-myc protein content in response to growth-inhibitory conditions, or to relate such changes to total cellular protein (TCP) levels, %S phase cells and/or cellular growth balance. Knowledge of such relationships is important for determining the biological relevance of the c-myc protein as a marker for proliferating cells. In this study, a dual-laser flow cytometric technique employing three fluorescent dyes was used to quantify cellular changes in c-myc protein, TCP, DNA and growth balance in exponentially-growing and serum deprived U118MG, A-172 and HL-60 cells. Results obtained by flow cytometry were verified using other techniques. Changes in c-myc protein content were found to occur independently of changes in TCP, %S phase or cellular growth balance, and varied between cell lines. These results indicate that cellular c-myc protein determinations convey information that is unique from other indicators of cellular growth and proliferation. Such information may be linked, however, to the nutritional status and origin of the cells being assayed.

摘要

c-myc蛋白是最早被发现与肿瘤细胞增殖活性增加相关的原癌基因产物之一。然而,很少有研究试图量化在生长抑制条件下细胞c-myc蛋白含量的变化,或将这些变化与细胞总蛋白(TCP)水平、S期细胞百分比和/或细胞生长平衡联系起来。了解这些关系对于确定c-myc蛋白作为增殖细胞标志物的生物学相关性很重要。在本研究中,采用一种使用三种荧光染料的双激光流式细胞术技术,来量化指数生长和血清剥夺的U118MG、A-172和HL-60细胞中c-myc蛋白、TCP、DNA和生长平衡的细胞变化。通过流式细胞术获得的结果使用其他技术进行了验证。发现c-myc蛋白含量的变化独立于TCP、S期百分比或细胞生长平衡的变化,并且在细胞系之间有所不同。这些结果表明,细胞c-myc蛋白的测定传达了与细胞生长和增殖的其他指标不同的独特信息。然而,这些信息可能与被检测细胞的营养状态和来源有关。

相似文献

1
A quantitative analysis of modulations occurring in cellular c-myc protein content, %S phase and growth balance under growth-inhibitory conditions.在生长抑制条件下,对细胞c-myc蛋白含量、S期百分比和生长平衡中发生的调节进行定量分析。
Cell Mol Biol (Noisy-le-grand). 1993 Sep;39(6):607-20.
2
Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.佛波酯和γ-干扰素对c-myc癌基因表达的调节:流式细胞术评估
Oncogene. 1988 Oct;3(4):429-35.
3
Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).1-β-D-阿拉伯呋喃糖基胞嘧啶对表达c-Jun显性负性突变蛋白(TAM67)的人单核细胞白血病细胞(U937)凋亡和分化的影响。
Cell Growth Differ. 1996 May;7(5):603-13.
4
Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.重组人转化生长因子-β1 或/和白细胞介素-6 对人白血病细胞生长抑制及原癌基因 c-myc 表达的影响
Chin Med J (Engl). 1997 Nov;110(11):847-50.
5
Investigations of mechanisms of drug-induced changes in gene expression: N-methylformamide-induced changes in synthesis of the M(r) 72,000 constitutive heat shock protein during commitment of HL-60 cells to granulocyte differentiation.药物诱导基因表达变化机制的研究:N-甲基甲酰胺诱导HL-60细胞向粒细胞分化过程中M(r) 72,000组成型热休克蛋白合成的变化。
Cancer Res. 1993 Jul 1;53(13):3034-9.
6
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.c-Myc的过表达抑制p21WAF1/CIP1的表达,并诱导对12-O-十四烷酰佛波醇-13-乙酸酯(TPA)敏感的人类癌细胞进入S期。
Cell Growth Differ. 1999 Apr;10(4):223-30.
7
Growth factor-dependent regulation of survivin by c-myc in human breast cancer.c-myc在人乳腺癌中对survivin的生长因子依赖性调控
J Mol Endocrinol. 2006 Dec;37(3):377-90. doi: 10.1677/jme.1.02118.
8
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.视网膜母细胞瘤蛋白(pRb)/E2F信号通路的破坏以及细胞凋亡的抑制是在持续表达c-myc和转化生长因子α的肝脏中发生的主要致癌事件。
Cancer Res. 1998 Jan 1;58(1):123-34.
9
Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.佛波酯抗性癌细胞中p21WAF1/CIP1、Rb和c-myc信号通路的缺陷。
Cancer Res. 1997 Jan 15;57(2):320-5.
10
Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.一种靶向c-myc的硫代磷酸酯三链形成寡核苷酸在人白血病细胞中的抗基因和抗增殖作用。
Cancer Res. 2000 Jul 15;60(14):3790-9.

引用本文的文献

1
Analysis of c-erbB2 protein content of human glioma cells and tumor tissue.人胶质瘤细胞和肿瘤组织中c-erbB2蛋白含量分析。
J Neurooncol. 1995;23(1):31-40. doi: 10.1007/BF01058457.